SuperworthArmata Pharmaceuticals market cap ARMP
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $135.3M
- Highest close in our data
- $473.3M
- Apr 2026
Armata Pharmaceuticals is worth $135.3M at the close on Oct 23, 2026, at $3.64 a share.
That is down 38% over the last year and up 70% over five years.
Its highest close in our data was $473.3M in Apr 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $135.3M | $125.3M | $473.3M | −43% |
| 2025 | $239.1M | $34.7M | $266.3M | +213% |
| 2024 | $76.3M | $70.6M | $151.1M | −35% |
| 2023 | $117.1M | $40.8M | $157.2M | +161% |
| 2022 | $44.8M | $44.8M | $177.8M | −70% |
| 2021 | $148.4M | $62.8M | $153.3M | +166% |
| 2020 | $55.8M | $26.3M | $78.3M | +74% |
| 2019 | $32M | $6.6M | $46.8M | +385% |
| 2018 | $6.6M | $4.8M | $21.5M | −31% |
| 2017 | $9.6M | $1.7M | $11.1M | +96% |
| 2016 | $4.9M | $4.9M | $26.9M | −79% |
| 2015 | $23.4M | $17.4M | $74.2M | −23% |
| 2014 | $30.5M | $28.1M | $87.6M | n/a |
Against its peers
Companies in Healthcare nearest Armata Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| ARMPArmata Pharmaceuticals | $135.3M |
| KEQUKewaunee Scientific | $94.9M |
| ICCCImmucell | $93.1M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| ELMDElectromed | $220.6M |
| UTMDUtah Medical Products | $236.3M |
| LFVNLifevantage | $73.4M |
| INFUInfuSystem | $277.6M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $202.4M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Armata Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.